Toshima Z Parris

11PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsGene and molecular therapyAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 02, 2026
Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer.

|Apr 16, 2025
Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden.

Anna-Karin Tzikas, Erik Holmberg, Toshima Z Parris

|Aug 13, 2024
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties.

Peter Larsson, Maria Cristina De Rosa, Benedetta Righino

|Aug 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers.

Peter Larsson, Maxim Olsson, Sithumini Sarathchandra

|Jul 13, 2024
Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate.

Charlotte Ytterbrink, Emman Shubbar, Toshima Z Parris

|Jan 29, 2024
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.

Peter Larsson, Daniella Pettersson, Maxim Olsson

Pageof 2

Frequent Collaborators

3 joint publications

Per Karlsson

2 joint publications

Khalil Helou

2 joint publications

Eva Forssell-Aronsson

1 joint publications

Nina Oparina